VRCA Reports $35.6M Revenue, $15.3M YCANTH Net, +130% YoY, 99% Unit Growth, Phase 3 Advances, Debt-Free, Cash to 2027
Verrica Pharmaceuticals Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.90
-5.8% since the alert
$6.26 → $5.90
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS